⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Kidney-Sparing Surgery Compared With Kidney Removal in Treating Patients With Kidney Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Kidney-Sparing Surgery Compared With Kidney Removal in Treating Patients With Kidney Cancer

Official Title: A Prospective Randomized Phase III Study Comparing Radical Surgery to Elective Kidney Sparing Surgery for Low Stage Renal Cell Carcinoma

Study ID: NCT00002473

Conditions

Kidney Cancer

Study Description

Brief Summary: RATIONALE: Kidney-sparing surgery is a less invasive type of surgery for kidney cancer, and may have fewer side effects and improve recovery. It is unknown whether kidney-sparing surgery is more effective than kidney removal in treating kidney cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of surgery to completely remove the kidney with kidney-sparing surgery in treating patients with resectable kidney cancer.

Detailed Description: OBJECTIVES: * Compare time to recurrence and survival of patients with single, low stage, nonmetastatic, well localized, and well delineated renal cell cancer treated with partial vs radical resection. * Establish the side effects of kidney-sparing tumor resection in terms of morbidity and mortality in these patients. * Study the relationship between tumor size, histologic grade, histologic type, and the extent of local control following partial resection. * Determine which prognostic factors are important in selecting candidates for conservative surgery. OUTLINE: This is a randomized, multicenter study. Patients are randomized to undergo radical nephrectomy and limited lymphadenectomy (arm I) or conservative surgery (arm II). Patients are followed every 3 months for 1 year, every 4 months for 2 years, every 6 months for 2 years, then annually thereafter. PROJECTED ACCRUAL: A total of 1300 patients will be accrued for this study over 8 years.

Eligibility

Minimum Age:

Eligible Ages: CHILD, ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Sunnybrook and Women's College Health Sciences Centre, North York, Ontario, Canada

McGill University, Montreal, Quebec, Canada

Contact Details

Name: Hein van Poppel, MD, PhD

Affiliation: University Hospital, Gasthuisberg

Role: STUDY_CHAIR

Name: Thomas Keane, MD

Affiliation: Emory University

Role: STUDY_CHAIR

Name: Leonard G. Gomella, MD

Affiliation: Sidney Kimmel Cancer Center at Thomas Jefferson University

Role: STUDY_CHAIR

Name: Eila C. Skinner, MD

Affiliation: University of Southern California

Role: STUDY_CHAIR

Name: Laurence H. Klotz, MD

Affiliation: Toronto Sunnybrook Regional Cancer Centre

Role: STUDY_CHAIR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: